Value of serum carbohydrate antigens 19-9 and 24-2 in diagnosis of benign and malignant biliary tract diseases

Cui DaPeng; Zhang YingChun; Gao ShuQuan; Han Lei; Zhang YiJun; Zhao LiJuan; Liu ZhenXian; Yang He

doi:10.3969/j.issn.1001-5256.2016.07.033

Issue 7

Jul. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(7): 1364-1367

PDF( 1521 KB)

Value of serum carbohydrate antigens 19-9 and 24-2 in diagnosis of benign and malignant biliary tract diseases

DOI: 10.3969/j.issn.1001-5256.2016.07.033

Research funding:

Published Date: 2016-07-20

Abstract

Abstract

Objective To investigate the value of serum carbohydrate antigen 19- 9( CA19- 9) and carbohydrate antigen 24- 2( CA24-2) in the diagnosis of benign and malignant biliary tract diseases. Methods A total of 214 patients with biliary tract diseases who were hospitalized in Department of Gastroenterology and Department of General Surgery in the First Hospital Affiliated to Hebei North University from January 2012 to October 2015 were enrolled,and according to the nature of lesions,they were divided into benign lesion group( 162 patients) and malignant lesion group( 52 patients). The healthy people who underwent physical examination during the same period of time in the Physical Examination Center were enrolled as normal control group( 40 persons). Peripheral venous blood was collected for all subjects in a fasting state,and the serum levels of total bilirubin( TBil),direct bilirubin( DBil),and indirect bilirubin( IBil) were measured. Radioimmunoassay was used to measure the serum levels of CA19- 9 and CA24- 2. The Kruskal- Wallis H test was used for comparison of continuous data between multiple groups,and the Wilcoxon rank sum test was used for further comparison between any two groups; the chi-square test was used for comparison of categorical data between groups; Pearson correlation analysis was also performed. Results Compared with the normal control group,the benign lesion group and the malignant lesion group showed significant increases in the serum levels of TBil and CA19- 9( all P < 0. 01). Compared with the benign lesion group,the malignant lesion group showed significant increases in the serum levels of CA19- 9 and CA24- 2( all P < 0. 01). The serum levels of CA19- 9 and CA24- 2 were not associated with tumor location in cholangiocarcinoma,but they were associated with the degree of tumor differentiation( χ2= 6. 860 and 9. 010,all P < 0. 05). The combined measurementof CA 1 9- 9 and CA 2 4- 2 had a sensitivity of 8 8. 5 % and a specificity of 8 2. 1 % in the diagnosis of cholangiocarcinoma,which were significantly higher than the sensitivity and specificity of CA19- 9 or CA24- 2 measurement( all P < 0. 01). In the patients with benign biliary tract diseases and cholangiocarcinoma,serum CA19- 9 was positively correlated with serum TBil( r = 0. 634 and 0. 346,both P < 0. 05),and the benign lesion group had a significantly greater correlation between serum CA19- 9 and serum TBil than the malignant lesion group. Conclusion Combined measurement of CA19- 9 and CA24- 2 has clinical significance in early diagnosis of cholangiocarcinoma.
- biliary tract diseases,
- antigens,
- tumor-associated

FullText(HTML)

References(15)

References

[1]XIONG HL,FAN Y,HU M,et al.The clinical value of serum CA199 in benign and malign biliary tract disease[J].Chin J Clin Gastroenterol,2013,25(6):327-329.(in Chinese)熊会玲,范彦,胡美,等.血清CA199对良恶性胆道疾病的意义[J].临床消化病杂志,2013,25(6):327-329.

[2]LIU SL,XING GZ,ZHANG YH,et al.The valuable tumormarkers of CEA and CA19-9 in the bile for diagnosis of cholangiocarcinoma and carcinoma of ampulla[J].J Clin Hepatol,2009,25(2):125-126.(in Chinese)刘素丽,邢国璋,张月寒,等.胆汁CEA、CA19-9联合检测对肝外胆管癌及壶腹癌的诊断价值[J].临床肝胆病杂志,2009,25(2):125-126.

[3]JIN ZD,LI ZS.Digestive Ultrasonic Endoscopy[M].Beijing:Science Press,2006:421-548.(in Chinese)金震东,李兆申.消化超声内镜学[M].北京:科学出版社,2006:421-548.

[4]CHEN WW,ZHOU SS,YAN S.Value of combined measurement of serum CA19-9 and CA242 in diagnosis of cholangiocarcinoma[J].Zhejiang Clin Med J,2014,16(3):368-369.(in Chinese)陈微微,周思思,严苏.血清CA19-9 CA242联合检测诊断胆管癌的价值[J].浙江临床医学,2014,16(3):368-369.

[5]CHUNG YJ,CHOI DW,CHOI SH,et al.Prognostic factors following surgical resection of distal bile duct cancer[J].J Korean Surg Soc,2013,85(5):212-218.

[6]DONG CG,WANG SM,SU WB.Research progress on combined measurement of tumor markers in the diagnosis of hilar cholangiocarcinoma[J].China Modern Med,2015,5(22):17-19.(in Chinese)董晨光,王世明,苏文博.肿瘤标志物联合检测在肝门胆管癌诊断中的研究进展[J].中国当代医药,2015,5(22):17-19.

[7]ZHU YB,GE SH,ZHANG LH,et al.Clinical value of serum CEA,CA19-9,CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer[J].Chin J Gastrointestinal Surg,2012,15(2):161-164.(in Chinese)朱昱冰,葛少华,张连海,等.肿瘤标志物在胃癌患者中的诊断及预后价值[J].中华胃肠外科杂志,2012,15(2):161-164.

[8]CHEN LB,HUANG DB.Diagnostic value of joint determination of serum CA199,CysC and Hcy levels in patients with pancreatic cancer[J].Chin J Health Lab Tec,2014,24(9):1265-1266.(in Chinese)陈乐宝,黄东标.CA199、CysC和Hcy联检对胰腺癌的诊断价值[J].中国卫生检验杂志,2014,24(9):1265-1266.

[9]LI J,LIANG XF,ZHAI GL.Application of combined detection of serum levels of CA199,CA125 and CEA in diagnosis of pancreatic cancer[J].J Jilin Univ:Med Edit,2014,40(6):1252-1255.(in Chinese)李静,梁晓芳,翟桂兰.血清CA199、CA125和CEA联合检测在胰腺癌诊断中的应用[J].吉林大学学报:医学版,2014,40(6):1252-1255.

[10]HOU JJ,HU SY,LIU TT,et al.Clinical value of serum tumor marker in early diagnosis ovarian cancer[J].Chin J Immunol,2014,30(8):1101-1107.(in Chinese)侯娟娟,虎淑妍,刘婷婷,等.血清肿瘤标志物在卵巢癌早期诊断中的临床价值[J].中国免疫学杂志,2014,30(8):1101-1107.

[11]FENG J,SHEN Q,PAN QC.The clinical significance of serum tumor markers in patients with choledocholithiasis[J].Chin J Gastroenterol Hepatol,2016,25(2):212-214.(in Chinese)冯洁,沈强,潘勤聪.胆总管结石患者血清肿瘤标志物的临床意义[J].胃肠病学和肝病学杂志,2016,25(2):212-214.

[12]SONG HW,JIANG YG,ZHANG SJ,et al.Relationship of serum CA199 levels with cholangiolithiasis and cholangitis[J].Chin JGastroenterol Hepatol,2013,22(12):1267-1268.(in Chinese)宋惠雯,蒋义贵,张生君,等.血清CA199与胆管结石及胆管炎的关系[J].胃肠病学和肝病学杂志,2013,22(12):1267-1268.

[13]TZENG CW,BALACHANDRAN A,AHMAD M,et al.Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer[J].HPB(Oxford),2014,16(5):430-438.

[14]CHEN S,MU D,CUI M,et al.Dynamic changes and clinical significance of serum tryptase levels in STEMI patients treated with primary PCI[J].Biomarkers,2014,19(7):620-624.

[15]LIN MS,HUANG JX,YU H.Elevated serum level of carbohydrate antigen 19-9 in benign biliary stricture diseases can reduce its value as a tumor marker[J].Int J Clin Exp Med,2014,7(3):744-750.

Relative Articles

[1]	Zhiran YANG, Linheng WANG, Yuan LI, Fusheng LIU, Yu WANG, Jianfang WANG, Runhua CHEN. Diagnostic value of transient elastography in the staging of hepatic fibrosis in patients with autoimmune liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(1): 97-103. doi: 10.3969/j.issn.1001-5256.2022.01.015
[2]	Liangliang GAN, Jinzhou ZHANG, Xiandong WANG, Caihong FU, Jia SU, Xuemei TANG. Efficacy of artificial liver support system in treatment of acute-on-chronic liver failure: A network Meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(1): 135-140. doi: 10.3969/j.issn.1001-5256.2022.01.021
[3]	Fei LIU, Hai LI, Qiang WU. Risk factors for bile leakage after hepatectomy without biliary reconstruction: A Meta - analysis[J]. Journal of Clinical Hepatology, 2022, 38(3): 594-600. doi: 10.3969/j.issn.1001-5256.2022.03.019
[4]	Xin DAI, Hanlin LIU, Long CHENG, Zhulin LUO, Tao WANG. Association of programmed death-1 and programmed death-ligand 1 with the prognosis and clinical features of patients with hepatocellular carcinoma: A meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1577-1583. doi: 10.3969/j.issn.1001-5256.2022.07.022
[5]	Tingpeng HU, Sudan TANG, Zebo YU. Relationship between vitamin D level in children and adolescents with nonalcoholic fatty liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(3): 627-631. doi: 10.3969/j.issn.1001-5256.2021.03.024
[6]	Weiming YU, Wenqian HONG, Binglun SUN, Jingzhao HAN, Hongfang TUO. Value of albumin-bilirubin grade in predicting liver function changes and prognosis of hepatocellular carcinoma patients undergoing transarterial chemoembolization: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(11): 2575-2583. doi: 10.3969/j.issn.1001-5256.2021.11.018
[7]	Huaqiang ZHANG, Lixin LIU, Xiaohong GUO. Association of nonalcoholic fatty liver disease with the risk of colorectal adenoma and colorectal cancer: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(7): 1619-1625. doi: 10.3969/j.issn.1001-5256.2021.07.028
[8]	Ying LIU, Benjian GAO, Xiaoli YANG, Cheng FANG, Song SU, Bo LI. Effect of hemihepatic vascular exclusion versus total hepatic vascular exclusion in hepatectomy for primary liver cancer: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(1): 73-78. doi: 10.3969/j.issn.1001-5256.2021.01.015
[9]	Shun ZHU, Zhiguo LI, Shuo LI, Xu CAO, Xiaobin LI, Xiaoke LI, Yongan YE. Effect of aspirin on the incidence rate of liver cancer in patients with viral hepatitis: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(5): 1097-1102. doi: 10.3969/j.issn.1001-5256.2021.05.024
[10]	Quan ZHOU, Lihui YANG, Fangqing JIANG. Long-term prognosis of patients with hepatitis C virus-related hepatocellular carcinoma receiving direct-acting antiviral: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(8): 1836-1840. doi: 10.3969/j.issn.1001-5256.2021.08.018
[11]	Minjun LI, Zhujian DENG, Haotian LIU, Yuxian TENG, Rongrui HUO, Xiumei LIANG, Bangde XIANG, Lequn LI, Jianhong ZHONG. Clinical effect of re-hepatic resection versus radiofrequency ablation in treatment of recurrent hepatocellular carcinoma in Asia: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(5): 1103-1109. doi: 10.3969/j.issn.1001-5256.2021.05.025
[12]	Yisheng PENG, Pan HE, Gang ZHU, Xinkai LI, Shunde TAN, Jianfei CHEN, Jun FAN, Bin LUO, Song SU, Bo LI, Xiaoli YANG. Efficacy and safety of CalliSpheres microsphere versus conventional transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(8): 1841-1847. doi: 10.3969/j.issn.1001-5256.2021.08.019
[13]	Liu ShenShen, Xing YiQing, Wang Ning, Yu QiaoLing, Ceng LePing. Clinical effect of vitamin E in treatment of nonalcoholic fatty liver disease in children: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(7): 1545-1550. doi: 10.3969/j.issn.1001-5256.2020.07.019
[14]	Tian Bing, Li Fan, Deng BaoCheng. Clinical effect of artificial liver support system in treatment of drug-induced liver failure: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(4): 823-828. doi: 10.3969/j.issn.1001-5256.2020.04.023
[15]	Wang XiangHong, Ma BaoHua, Zou XiuLan, Yao KeCheng, He Qian. Association between nonalcoholic fatty liver disease and epicardial adipose tissue: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(6): 1304-1309. doi: 10.3969/j.issn.1001-5256.2020.06.023
[16]	Qian Le, Ying Li. Selection of second-line drugs for adult autoimmune hepatitis: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(9): 2015-2020. doi: 10.3969/j.issn.1001-5256.2020.09.021
[17]	Sun DongXue, Yang Zhu, Long FengXi, Wei XianMan, Tang DongXin. Efficacy and safety of Kanglaite injection combined with transarterial chemoembolization in treatment of advanced liver cancer: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(2): 363-368. doi: 10.3969/j.issn.1001-5256.2020.02.026
[18]	Tang JinQuan, He Pan, Su Song, Luo Bin, Fang Cheng, Li Bo, Xia XianMing, Li YuWei. Short-and long-term effects of radiofrequency ablation versus minimally invasive hepatectomy in treatment of small hepatocellular carcinoma: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(2): 358-362. doi: 10.3969/j.issn.1001-5256.2020.02.025
[19]	Wang Le, Liu LiXin, Guo XiaoHong. Value of contrast-enhanced endoscopic ultrasonography in the differential diagnosis of mass-type chronic pancreatitis and pancreatic cancer:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2246-2251. doi: 10.3969/j.issn.1001-5256.2019.10.023
[20]	Li Dong, Luo TianYang, Ran YaWei. Value of contrast-enhanced computed tomography and magnetic resonance imaging in diagnosis of residual or recurrent lesion after transcatheter arterial chemoembolization in hepatocellular carcinoma:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2214-2219. doi: 10.3969/j.issn.1001-5256.2019.10.017

Supplements(0)

Cited By

Cited by

Periodical cited type(4)

1.	白丽萍，张颖慧，杨雪艳，白丽仙，马志坚. 昆明地区HBsAg与抗-HBs双阳性慢性HBV感染患者流行病学调查及PreS/S基因突变特征. 西部医学. 2023(12): 1793-1797 .
2.	颜建飞，陈方红，卢伟业，陈志辉，潜潇. 超声造影LI-RADS在隐匿性乙肝患者肝细胞癌诊断中的应用. 温州医科大学学报. 2022(10): 818-822 .
3.	雷泽慧. 增强CT诊断肝细胞癌肾上腺腺瘤与转移瘤的价值分析. 实用医学影像杂志. 2021(01): 55-57 .
4.	钟霞，潘建华，童坚. 海南某院孕妇HBV、HCV和梅毒螺旋体检测结果分析. 传染病信息. 2021(02): 160-161 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2440) PDF downloads(431)

Value of serum carbohydrate antigens 19-9 and 24-2 in diagnosis of benign and malignant biliary tract diseases

DOI: 10.3969/j.issn.1001-5256.2016.07.033